Brad Wyman has twenty years of experience in pharmaceutical, biological, medical device and drug development. He has worked across all phases of clinical testing and across multiple therapeutic areas with a focus on the implementation of complex imaging biomarkers from phase 1 through phase 4. He has also successfully designed and delivered medical devices including implementation of Quality Systems Regulations (QSR) and submission of 510ks. He worked for several small medical device companies and then moved to Pfizer to apply medical imaging to the evaluation of their pharmaceutical pipeline. Brad now runs OThree Consulting offering services for pharmaceutical, medical device and contract research companies. He received a B.S. at BYU, an M.S. at Northwestern, both in electrical engineering, and a PhD in biomedical engineering at the Johns Hopkins School of Medicine and has published over 50 journal articles and has 4 issued patents.